Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$615M |
| 2 |
Uber
UBER
|
+$551M |
| 3 |
Expedia Group
EXPE
|
+$523M |
| 4 |
PayPal
PYPL
|
+$452M |
| 5 |
Eaton
ETN
|
+$408M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$681M |
| 2 |
RTN
Raytheon Company
RTN
|
+$543M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$537M |
| 4 |
Charter Communications
CHTR
|
+$472M |
| 5 |
SPDR Gold Trust
GLD
|
+$464M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.14% |
| 2 | Financials | 4.52% |
| 3 | Industrials | 4.17% |
| 4 | Healthcare | 3.91% |
| 5 | Consumer Discretionary | 3.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LGF.B
8226
PUT
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
| $138K | ﹤0.01% |
+13,900
| New | +$120K |
|
|
ASRT
8227
DELISTED
Assertio
ASRT
| $137K | ﹤0.01% |
1,823
-1,917
| -51% | -$112K |
|
8228
PUT
W&T Offshore
WTI
$518M
| $137K | ﹤0.01% |
24,600
-77,800
| -76% | -$346K |
|
|
NPKI
8229
NPK International
NPKI
$1.14B
| $137K | ﹤0.01% |
+21,842
| New | +$142K |
|
|
NPTN
8230
CALL
DELISTED
NEOPHOTONICS CORP
NPTN
| $137K | ﹤0.01% |
+15,500
| New | +$116K |
|
|
GSS
8231
PUT
DELISTED
Golden Star Resources Ltd.
GSS
| $137K | ﹤0.01% |
35,900
-19,500
| -35% | -$62.3K |
|
8232
PUT
Amplify Energy
AMPY
$166M
| $136K | ﹤0.01% |
20,600
+1,100
| +6% | +$7.08K |
|
8233
CALL
Northern Oil and Gas
NOG
$2.35B
| $136K | ﹤0.01% |
5,800
-11,360
| -66% | -$225K |
|
8234
PUT
Turkcell
TKC
$4.79B
| $135K | ﹤0.01% |
23,200
-175,500
| -88% | -$1M |
|
|
BHR
8235
PUT
Braemar Hotels & Resorts
BHR
$142M
| $134K | ﹤0.01% |
15,000
-61,053
| -80% | -$571K |
|
8236
CALL
B2Gold
BTG
$6.64B
| $134K | ﹤0.01% |
+33,500
| New | +$118K |
|
8237
CALL
Ironwood Pharmaceuticals
IRWD
$714M
| $134K | ﹤0.01% |
+10,100
| New | +$111K |
|
|
AVEO
8238
PUT
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
| $134K | ﹤0.01% |
21,430
+2,040
| +11% | +$15K |
|
|
SPN
8239
DELISTED
Superior Energy Services, Inc.
SPN
| $133K | ﹤0.01% |
+26,540
| New | +$132K |
|
8240
CALL
Lexicon Pharmaceuticals
LXRX
$1.1B
| $132K | ﹤0.01% |
31,900
+400
| +1% | +$1.54K |
|
8241
PUT
Resideo Technologies
REZI
$3.95B
| $132K | ﹤0.01% |
+11,100
| New | +$126K |
|
8242
Suzano
SUZ
$10.1B
| $132K | ﹤0.01% |
+13,422
| New | +$119K |
|
|
ENLC
8243
CALL
DELISTED
ENLINK MIDSTREAM, LLC
ENLC
| $132K | ﹤0.01% |
21,600
-420,500
| -95% | -$2.55M |
|
|
ATHX
8244
DELISTED
Athersys, Inc. Common Stock
ATHX
| $132K | ﹤0.01% |
4,278
+3,191
| +294% | +$105K |
|
|
STML
8245
PUT
DELISTED
Stemline Therapeutics, Inc.
STML
| $132K | ﹤0.01% |
+12,400
| New | +$123K |
|
8246
CALL
Costamare
CMRE
$1.77B
| $131K | ﹤0.01% |
13,700
-12,500
| -48% | -$99.8K |
|
8247
Globalstar
GSAT
$10.8B
| $131K | ﹤0.01% |
16,932
+4,526
| +36% | +$27.4K |
|
8248
Harrow
HROW
$1.51B
| $131K | ﹤0.01% |
+16,834
| New | +$97.5K |
|
8249
Mitek Systems
MITK
$834M
| $131K | ﹤0.01% |
17,071
-60,230
| -78% | -$508K |
|
|
SMC
8250
Summit Midstream
SMC
$419M
| $131K | ﹤0.01% |
2,646
+1,580
| +148% | +$94.7K |
|
Similar funds
Citadel Advisors's Q4 2019 Portfolio in Review
As of Q4 2019, Citadel Advisors held 10,299 positions worth $230B, up 8.7% from $212B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Citadel Advisors withdrew a net $8.18B in Q4 2019, closing 1,266 positions and reducing 4,117 holdings. Its most notable exit was Celgene Corp, an estimated $681M position sold in full.
By sector, the portfolio is most concentrated in Technology at 5.1% of assets, down from 5.3% a quarter earlier, followed by Financials and Industrials.
Against the trend, Citadel Advisors opened a new position in Interxion Holding N.V. worth $83.9M.
- Citadel Advisors's largest Q4 2019 buy was Interxion Holding N.V.: 1,000,931 shares worth $83.9M.
- Citadel Advisors added most to Amazon in Q4 2019, an estimated $615M increase.
- Citadel Advisors's biggest Q4 2019 reduction was Raytheon Company, cutting an estimated $543M.
- Citadel Advisors fully exited Celgene Corp in Q4 2019, selling an estimated $681M.
- Citadel Advisors's ten largest holdings make up 23% of its $230B portfolio in Q4 2019.
- Citadel Advisors opened 1,220 new positions and closed 1,266 in Q4 2019.
- Citadel Advisors's portfolio value rose 8.7% quarter-over-quarter to $230B.
Based on Citadel Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.